<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "Nanoparticle delivery" OR "non-viral delivery"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Size-Tunable Strategies for a Tumor Targeted Drug Delivery System.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32123729">Link</a></p><p><b>Date:</b> 2020-03-03</p><p><b>Authors:</b> Wenqi Yu ...  Huile Gao</p><p><b>Journal:</b> ACS Cent Sci</p><p><b>IF (7 or above):</b> 9.65</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor effects are not always satisfactory due to the limited penetration and retention.  As we all know, there is a paradox that nanoparticles with large sizes tend to distribute around tumor blood vessels rather than ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: In situ genetic engineering of tumors for long-lasting and systemic immunotherapy.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32034097">Link</a></p><p><b>Date:</b> 2020-02-08</p><p><b>Authors:</b> Stephany Y Tzeng ...  Jordan J Green</p><p><b>Journal:</b> Proc. Natl. Acad. Sci. U.S.A.</p><p><b>IF (7 or above):</b> 9.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Cancer immunotherapy has been the subject of extensive research, but highly effective and broadly applicable methods remain elusive.  Moreover, a general approach to engender endogenous patient-specific cellular therapy, without the need for a priori knowledge of tumor antigen, ex vivo cellular mani ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32089747">Link</a></p><p><b>Date:</b> 2020-02-24</p><p><b>Authors:</b> Henriette S de Bruijn ...  Sabrina Oliveira</p><p><b>Journal:</b> Theranostics</p><p><b>IF (7 or above):</b> 8.02</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Targeted photodynamic therapy (PDT) has the potential to selectively damage tumor tissue and to increase tumor vessel permeability.  Here we characterize the tissue biodistribution of two EGFR-targeted nanobody-photosensitizer conjugates (NB-PS), the monovalent 7D12-PS and the biparatopic 7D12-9G8-P ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32042344">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Myrofora Panagi ...  Triantafyllos Stylianopoulos</p><p><b>Journal:</b> Theranostics</p><p><b>IF (7 or above):</b> 8.02</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Tumor normalization strategies aim to improve tumor blood vessel functionality (i. e.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31981492">Link</a></p><p><b>Date:</b> 2020-01-25</p><p><b>Authors:</b> Jiahui Wu ...  Colin J Chu</p><p><b>Journal:</b> Mol. Ther.</p><p><b>IF (7 or above):</b> 7.47</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Glaucoma is a common cause of blindness, yet current therapeutic options are imperfect.  Clinical trials have invariably shown that reduction in intraocular pressure (IOP) regardless of disease subtype prevents visual loss.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31998833">Link</a></p><p><b>Date:</b> 2020-01-30</p><p><b>Authors:</b> Jimena G Dancy ...  Anthony J Kim</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Development of effective tumor cell-targeted nanodrug formulations has been quite challenging, as many nanocarriers and targeting moieties exhibit nonspecific binding to cellular, extracellular, and intravascular components.  We have developed a therapeutic nanoparticle formulation approach that bal ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32064335">Link</a></p><p><b>Date:</b> 2020-02-17</p><p><b>Authors:</b> Hongmei Chen ...  Tianmeng Sun</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> CCR9</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: On the design of precision nanomedicines.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32042891">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Xiaohe Tian ...  Giuseppe Battaglia</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Tight control on the selectivity of nanoparticles' interaction with biological systems is paramount for the development of targeted therapies.  However, the large number of tunable parameters makes it difficult to identify optimal design "sweet spots" without guiding principles.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Poly(vinyl alcohol) boosting therapeutic potential of </h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32010792">Link</a></p><p><b>Date:</b> 2020-02-05</p><p><b>Authors:</b> Takahiro Nomoto ...  Nobuhiro Nishiyama</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> In the current clinical boron neutron capture therapy (BNCT), </p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32080183">Link</a></p><p><b>Date:</b> 2020-02-22</p><p><b>Authors:</b> Siddharth Patel ...  Gaurav Sahay</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Endosomal sequestration of lipid-based nanoparticles (LNPs) remains a formidable barrier to delivery.  Herein, structure-activity analysis of cholesterol analogues reveals that incorporation of C-24 alkyl phytosterols into LNPs (eLNPs) enhances gene transfection and the length of alkyl tail, flexibi ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32111847">Link</a></p><p><b>Date:</b> 2020-02-29</p><p><b>Authors:</b> Min Li ...  Yucai Wang</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The efficacy of nano-mediated drug delivery has been impeded by multiple biological barriers such as the mononuclear phagocyte system (MPS), as well as vascular and interstitial barriers.  To overcome the abovementioned obstacles, we report a nano-pathogenoid (NPN) system that can in situ hitchhike  ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Lymphatic endothelial cells prime naïve CD8</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31988323">Link</a></p><p><b>Date:</b> 2020-01-28</p><p><b>Authors:</b> Efthymia Vokali ...  Melody A Swartz</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Lymphatic endothelial cells (LECs) chemoattract naïve T cells and promote their survival in the lymph nodes, and can cross-present antigens to naïve CD8</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31980606">Link</a></p><p><b>Date:</b> 2020-01-25</p><p><b>Authors:</b> Koji M Nishiguchi ...  Toru Nakazawa</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Supplementing wildtype copies of functionally defective genes with adeno-associated virus (AAV) is a strategy being explored clinically for various retinal dystrophies.  However, the low cargo limit of this vector allows its use in only a fraction of patients with mutations in relatively small patho ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Roles of circRNAs in the tumour microenvironment.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31973726">Link</a></p><p><b>Date:</b> 2020-01-24</p><p><b>Authors:</b> Qiuge Zhang ...  Zhenqiang Sun</p><p><b>Journal:</b> Mol. Cancer</p><p><b>IF (7 or above):</b> 11.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The tumour microenvironment (TME) constitutes the area surrounding the tumour during its development and has been demonstrated to play roles in cancer-related diseases through crosstalk with tumour cells.  Circular RNAs (circRNAs) are a subpopulation of endogenous noncoding RNAs (ncRNAs) that are ub ....</p></div></td></div></tr></table></div><hr></div></body></html>